Top

Indian Journal of Pediatrics

Published in:

01-01-2014 | Original Article

Profile and Outcome of Childhood Tuberculosis Treated with DOTS—An Observational Study

Authors: Pushpa Panigatti, Vinod Hanumant Ratageri, Illalu Shivanand, P. K. Madhu, T. A. Shepur

Published in: Indian Journal of Pediatrics | Issue 1/2014

Abstract

Objectives

To study the clinical profile and outcome of childhood tuberculosis treated with Directly Observed Treatment Short (DOTS) course regimen. Also to study the side effects of anti-tubercular treatment (ATT).

Methods

This prospective hospital based observational study was conducted at Department of Pediatrics, Karnataka Institute of Medical Sciences (KIMS), Hubli. Inclusion criteria were i) All newly diagnosed cases of tuberculosis from 0 to 12 y of age. ii) Children with relapse, treatment failure or defaulters. Exclusion criteria was children with tuberculosis on anti-tubercular treatment (ATT) other than DOTS regimen. A detailed history including demographic profile and clinical examination were carried out for each case. Diagnosis, categorization, treatment (DOTS regimen) and outcome measures were defined according to WHO/RNTCP guidelines. Data was analyzed using SPSS 17.

Results

Total number of children enrolled in the study were 93. Mean age was 6 y. Male to female ratio was 0.9:1. Extra pulmonary tuberculosis (EPTB) was common 58 (62.4 %) than pulmonary tuberculosis 35 (37.6 %). The common symptoms/signs were fever (83.8 %), cough (46.2 %), convulsion (17.2 %), loss of appetite (11.8 %) and pallor (75.3 %), lymphadenopathy (18.3 %), hepatomegaly (9.7 %) and splenomegaly (6.5 %). Mantoux test was positive in 59 (63.4 %) children. Acid fast bacilli (AFB) was isolated in 13 (14 %) children in various fluid/histological specimens. The prevalence of HIV infection was 7.5 %. Among 93 children, 88(94.6 %) completed treatment and were declared cured; four children were lost to follow up and one child died. Compliance of DOTS was good and there were no side effects due to ATT.

Conclusions

EPTB was common than pulmonary TB. Efficacy of DOTS in index study was 94.6 %. No adverse effects of ATT were observed.

Guidance for national tuberculosis programmes on the management of tuberculosis in children WHO/HTM/TB/2006.371.[Cited 2010 Aug 3]. Available from: URL:http://www.who.int/child_adolescent_health/documents/htm_tb_2006_371/en/index.html.

Vijayasekaran D. Treatment of childhood tuberculosis. Indian J Pediatr. 2011;78:443–8.PubMedCrossRef

Swaminathan S. Basic concepts in the treatment of tuberculosis. Indian J Pediatr. 2002;69:S44–9.PubMed

Frieden TR. Directly observed treatment, short-course (DOTS): Ensuring cure oftuberculosis. Indian J Pediatr. 2000;67:S21–7.

Chauhan LS, Arora VK, Central TB. Division, Directorate General of Health Services, Ministry of Health and Family Welfare; Indian Academy of Pediatrics. Management of pediatric TB under the Revised National Tuberculosis Control Programme (RNTCP). Indian Pediatr. 2004;41:901–5.PubMed

Kabra SK, Lodha R, Seth V. Category based treatment of tuberculosis in children. Indian Pediatr. 2004;41:927–37.

Arora VK, Gupta R. Directly observed treatment for tuberculosis. Indian J Pediatr. 2003;70:885–9.PubMedCrossRef

Gupta R, Garg A, Venkateshwar V, Kanitkar M. Spectrum of childhood tuberculosis in BCG vaccinated and unvaccinated children. MJAFI. 2009;65:305–7.

Balasubramanian VN, Oomen K, Samuel R. DOT or not? Direct observation of anti tuberculosis treatment and patient outcomes, Kerala state, India. Int J Tuberc Lung Dis. 2000;4:409–13.

10.

Indumathi CK, Prasanna KK, Dinakar C, Shet A, Lewin S. Intermittent short course therapy for pediatric tuberculosis. Indian Pediatr. 2010;47:93–6.

11.

Sivanandan S, Walia M, Lodha R, Kabra SK. Factors associated with treatment failure in childhood tuberculosis. Indian Pediatr. 2008;45:769–71.

12.

Bai SS, Devi RL. Clinical spectrum of tuberculosis in BCG vaccinated children. Indian Pediatr. 2002;39:458–62.PubMed

13.

Sharma S, Sarin R, Khalid UK, Singla N, Sharma PP, Behera D. Clinical profile and treatment outcome of tuberculous lymphadenitis in children using DOTS strategy. Indian J Tuberc. 2010;57:4–11.

14.

Shrestha S, Marahatta SB, Poudyal P, Shrestha SM. Clinical profile and outcome of childhood tuberculosis at Dhulikhel hospital. J Nepal Paediatr Soc. 2011;31:11–6.

15.

Sharma S, Sarin K, Khalid UK, Singla N, Sharma PP, Behera D. Clinical profile and treatment outcome of tubercular pleurisy in pediatric age group using DOTS strategy. Indian J Tuberc. 2009;56:191–200.PubMed

16.

Sreeramareddy CT, Ramakrishnareddy N, Shah RK, Baniya R, Swain PK. Clinico-epidemiological profile and diagnostic procedures of pediatric tuberculosis in a tertiary care hospital of western Nepal-a case-series analysis. BMC Pediatr. 2010;10:57.PubMedCentralPubMedCrossRef

17.

Pama CLP, Gatchalian SR. Clinical profile of culture-proven tuberculosis cases among Filipino children aged 3 months to 18 years. Phil J Microbiol Infect Dis. 2001;30:133–43.

18.

Datta M, Swaminathan S. Global aspects of tuberculosis in children. Paediatr Respir Rev. 2001;2:91–6.PubMedCrossRef

19.

Somu N, Vijayasekaran D, Kannaki M, Balachandran A, Subramanyam L. Adult contacts in children with tuberculosis. Indian Pediatr. 1997;34:819–22.PubMed

20.

Vijayasekaran D, Kumar AR, Gowrishankar NC, Nedunchelian K, Sethuraman S. Mantoux and contact positivity in tuberculosis. Indian J Pediatr. 2006;73:989–93.PubMedCrossRef

21.

Kiwanuka JP. Interpretation of tuberculin skin test results in the diagnosis of tuberculosis in children. Afr Health Sci. 2005;5:152–6.PubMedCentralPubMed

22.

Agarwal M, Koppikar GV, Ghildiyal R, Charvakar M, Joshi SM, Lahiri KR. Seropositivity rate for HIV infection in hospitalized children on selective screening. Indian Pediatr. 2001;38:267–71.

23.

Lahiri S, Shahab T, Malik A, Alam S. HIV seropositivity in hospitalized children with high likelihood of AIDS. Indian Pediatr. 2000;39:372–5.

24.

Shahab T, Zoha MS, Malik MA, Malik A, Afzal K. Prevalence of human immunodeficiency virus infection in children with tuberculosis. Indian Pediatr. 2004;41:595–9.PubMed

25.

Sharma S, Sarin R, Khalid UK, Singla N, Sharma PP, Behera D. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi. India Int J Tuberc Lung Dis. 2008;12:74–80.

26.

Hussain T, Sinha S, Talan S, Verma S, Yadav VS, Dayal R, et al. Seroprevalence of HIV infection among paediatric tuberculosis patients in Agra, India: A hospital-based study. Tuberculosis. 2007;87:7–11.

27.

Venugopal K, Sreelatha PR, Philip S, Kumar V. Treatment outcome of neuro tuberculosis patients put on DOTS-An observational study from the field. Indian J Tuberc. 2008;55:199–202.PubMed

28.

Harries AD, Hargreaves NJ, Graham SM, Mwansambo C, Kazembe P, Broadhead RL, et al. Childhood tuberculosis in Malawi: Nationwide case-finding and treatment outcomes. Int J Tuberc Lung Dis. 2002;6:424–31.

29.

Hong Kong Chest Service, British Medical Research Council. Controlled trial of four thrice weekly regimens and daily regimen all given for six months for pulmonary tuberculosis. Lancet. 1981;8213:171–4.

Title: Profile and Outcome of Childhood Tuberculosis Treated with DOTS—An Observational Study
Authors: Pushpa Panigatti
Vinod Hanumant Ratageri
Illalu Shivanand
P. K. Madhu
T. A. Shepur
Publication date: 01-01-2014
Publisher: Springer India
Published in: Indian Journal of Pediatrics / Issue 1/2014
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI: https://doi.org/10.1007/s12098-013-1175-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Profile and Outcome of Childhood Tuberculosis Treated with DOTS—An Observational Study

Abstract

Objectives

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2014

Irritant Contact Dermatitis due to “Kajal”

Precocious Puberty—Perspectives on Diagnosis and Management

Newborn Screening for G6PD Deficiency- Why is it Important for India?

Fascinating Interaction between Host and Pathogen

X Linked Agammaglobulinemia: A Single Centre Experience from India

The Maya Behind Moyamoya–The Two Extremes of the Disease : Authors’ Reply